Hockenberry Marilyn J, Hooke Mary C, Gregurich Maryann, McCarthy Kathy, Sambuco Gennaro, Krull Kevin
Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Cancer Center at Texas Children's Hospital, Houston, USA.
Oncol Nurs Forum. 2010 Jan;37(1):E16-27. doi: 10.1188/10.ONF.E16-E27.
PURPOSE/OBJECTIVES: To examine the influence of the proposed symptom cluster of fatigue, nausea and vomiting, and sleep disturbances on clinical outcomes defined as behavior changes, depression, and performance status in children and adolescents before and after receiving cisplatin, doxorubicin, or ifosfamide chemotherapy.
A prospective, descriptive, within-group, before-and-after-chemotherapy design was used.
Two major childhood cancer treatment hospitals in the United States.
67 patients aged 7-18 years who were receiving chemotherapy courses of cisplatin, doxorubicin, or ifosfamide.
Fatigue, depression, behavior, and performance assessments were completed on the first day of cisplatin, doxorubicin, or ifosfamide therapy and one week later. Patients wore a wrist actigraph on the nondominant hand during the course of therapy and for 48 hours after discharge from the hospital. Nausea and vomiting were measured every 24 hours during the course of therapy and for 48 hours after discharge. A linear mixed model was used to evaluate the influence of the symptom cluster. Regression analysis was used to examine the associations between performance status and the symptom cluster. Principal component analysis with varimax rotation was used to produce the correlation of sleep symptoms.
Fatigue, nausea and vomiting, sleep disturbances, behavior, depression, and performance.
Adolescents with the cluster of increased fatigue and sleep disturbances experienced more depressive symptoms and behavior changes. Children with higher levels of fatigue had increased depressive symptoms. The more fatigue parents perceived in their children or adolescents, the more behavior and emotional difficulties were reported.
Fatigue, sleep disturbance, and nausea and vomiting, when clustered, impacted depressive symptoms and behavior changes in adolescents after chemotherapy. In children, fatigue alone impacted depressive symptoms and behavior changes.
Symptom clusters can have a significant impact on children's and adolescents' quality of life during cancer treatment. Early recognition and intervention for these symptoms are an important nursing role.
目的/目标:研究疲劳、恶心呕吐和睡眠障碍这一症状群对接受顺铂、多柔比星或异环磷酰胺化疗的儿童和青少年化疗前后临床结局(定义为行为改变、抑郁和功能状态)的影响。
采用前瞻性、描述性、组内化疗前后设计。
美国两家主要的儿童癌症治疗医院。
67名年龄在7至18岁之间、正在接受顺铂、多柔比星或异环磷酰胺化疗疗程的患者。
在顺铂、多柔比星或异环磷酰胺治疗的第一天和一周后完成疲劳、抑郁、行为和功能评估。患者在治疗期间及出院后48小时佩戴非优势手的腕部活动记录仪。在治疗期间及出院后48小时每24小时测量一次恶心和呕吐情况。使用线性混合模型评估症状群的影响。采用回归分析检验功能状态与症状群之间的关联。使用主成分分析和方差最大化旋转来得出睡眠症状的相关性。
疲劳、恶心呕吐、睡眠障碍、行为、抑郁和功能。
疲劳和睡眠障碍增加的青少年出现更多抑郁症状和行为改变。疲劳程度较高的儿童抑郁症状增加。父母察觉到孩子或青少年的疲劳程度越高,报告的行为和情绪问题就越多。
疲劳、睡眠障碍以及恶心呕吐若聚集在一起,会影响化疗后青少年的抑郁症状和行为改变。在儿童中,仅疲劳就会影响抑郁症状和行为改变。
症状群可对癌症治疗期间儿童和青少年的生活质量产生重大影响。对这些症状的早期识别和干预是护理的重要职责。